Safety Assessment of Nanomaterials for Antimicrobial Applications

被引:37
作者
Ali, Arbab [1 ,2 ]
Ovais, Muhammad [2 ,3 ]
Cui, Xuejing [2 ]
Rui, Yukui [1 ]
Chen, Chunying [2 ,3 ,4 ]
机构
[1] China Agr Univ, Beijing Key Lab Farmland Soil Pollut Prevent & Re, Coll Resources & Environm Sci, Beijing 100193, Peoples R China
[2] Natl Ctr Nanosci & Technol, CAS Ctr Excellence Nanosci, CAS Key Lab Biomed Effects Nanomat & Nanosafety, Beijing 100190, Peoples R China
[3] Univ Chinese Acad Sci, Beijing 100049, Peoples R China
[4] GBA Res Innovat Inst Nanotechnol, Guangzhou 510700, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
ZINC-OXIDE NANOPARTICLES; MESOPOROUS SILICA NANOPARTICLES; UP-CONVERSION NANOPARTICLES; GOLD NANOPARTICLES; SILVER NANOPARTICLES; OXIDATIVE STRESS; CARBON NANOTUBES; IN-VITRO; ANTIBACTERIAL ACTIVITY; QUANTUM DOTS;
D O I
10.1021/acs.chemrestox.9b00519
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The interplay between nanotechnology and pathogens offers a new quest to fight against human infections. Inspiring from their unique thermal, magnetic, optical, or redox potentials, numerous nanomaterials have been employed for bacterial theranostics. The past decade has seen dramatic progress in the development of various nanoantimicrobials, which demands more focus on their safety assessment. The present review critically discusses the toxicity of nanoantimicrobials and the role of key features, including composition, size, surface charge, loading capability, hydrophobicity/philicity, precise release, and functionalization, that can contribute to modulating the effects on microbes. Moreover, how differences in microbe's structure, biofilm formation, persistence cells, and intracellular pathogens bestow resistance or sensitivity toward nanoantimicrobials is broadly investigated. In extension, the most important types of nanoantimicrobial with clinical prospective and their safety assessment are summarized, and finally, based on available evidence, an insight of the principles in designing safer nanoantimicrobials for overcoming pathogens and future challenges in the field is provided.
引用
收藏
页码:1082 / 1109
页数:28
相关论文
共 251 条
[1]   Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases [J].
Andrade, Fernando ;
Rafael, Diana ;
Videira, Mafalda ;
Ferreira, Domingos ;
Sosnik, Alejandro ;
Sarmento, Bruno .
ADVANCED DRUG DELIVERY REVIEWS, 2013, 65 (13-14) :1816-1827
[2]  
[Anonymous], 2018, High Levels of Antibiotic Resistance Found Worldwide, New Data Shows
[3]   Serum-borne bioactivity caused by pulmonary multiwalled carbon nanotubes induces neuroinflammation via blood-brain barrier impairment [J].
Aragon, Mario J. ;
Topper, Lauren ;
Tyler, Christina R. ;
Sanchez, Bethany ;
Zychowski, Katherine ;
Young, Tamara ;
Herbert, Guy ;
Hall, Pamela ;
Erdely, Aaron ;
Eye, Tracy ;
Bishop, Lindsey ;
Saunders, Samantha A. ;
Muldoon, Pretal P. ;
Ottens, Andrew K. ;
Campen, Matthew J. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (10) :E1968-E1976
[4]   Antibiotic-Resistant Bugs in the 21st Century -- A Clinical Super-Challenge. [J].
Arias, Cesar A. ;
Murray, Barbara E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (05) :439-443
[5]   Towards a definition of inorganic nanoparticles from an environmental, health and safety perspective [J].
Auffan, Melanie ;
Rose, Jerome ;
Bottero, Jean-Yves ;
Lowry, Gregory V. ;
Jolivet, Jean-Pierre ;
Wiesner, Mark R. .
NATURE NANOTECHNOLOGY, 2009, 4 (10) :634-641
[6]   Lanthanide-Doped Upconversion Nanoparticles: Emerging Intelligent Light-Activated Drug Delivery Systems [J].
Bagheri, Ali ;
Arandiyan, Hamidreza ;
Boyer, Cyrille ;
Lim, May .
ADVANCED SCIENCE, 2016, 3 (07)
[7]   Antibiotic-Induced Anomalous Statistics of Collective Bacterial Swarming [J].
Benisty, Sivan ;
Ben-Jacob, Eshel ;
Ariel, Gil ;
Be'er, Avraham .
PHYSICAL REVIEW LETTERS, 2015, 114 (01)
[8]   Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date [J].
Bobo, Daniel ;
Robinson, Kye J. ;
Islam, Jiaul ;
Thurecht, Kristofer J. ;
Corrie, Simon R. .
PHARMACEUTICAL RESEARCH, 2016, 33 (10) :2373-2387
[9]   Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity [J].
Boisselier, Elodie ;
Astruc, Didier .
CHEMICAL SOCIETY REVIEWS, 2009, 38 (06) :1759-1782
[10]   Distinguishing between resistance, tolerance and persistence to antibiotic treatment [J].
Brauner, Asher ;
Fridman, Ofer ;
Gefen, Orit ;
Balaban, Nathalie Q. .
NATURE REVIEWS MICROBIOLOGY, 2016, 14 (05) :320-330